CHAMPIX

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug CHAMPIX contains one active pharmaceutical ingredient (API):

1	Varenicline UNII 82269ASB48 - VARENICLINE TARTRATE
	Varenicline binds with high affinity and selectivity at the α4β2 neuronal nicotinic acetylcholine receptors, where it acts as a partial agonist – a compound that has both agonist activity, with lower intrinsic efficacy than nicotine, and antagonist activities in the presence of nicotine.
	Read more about Varenicline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CHAMPIX Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07BA03	Varenicline	N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BA Drugs used in nicotine dependence
Discover more medicines within N07BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5469W, 9128K, 9129L
BR	Câmara de Regulação do Mercado de Medicamentos	522720070088717, 522720070088817, 522720070088917, 522720070089017, 522720070089117, 522720070089217
CA	Health Products and Food Branch	02291177, 02291185, 02298309
EE	Ravimiamet	1260346, 1260357, 1260368, 1260379, 1260380, 1295771, 1403042, 1501625, 1774380
ES	Centro de información online de medicamentos de la AEMPS	06360001, 06360004IP, 06360011IP, 06360012IP, 106360016, 106360022, 106360023
FI	Lääkealan turvallisuus- ja kehittämiskeskus	058014, 066260, 130596, 161488, 551683
FR	Base de données publique des médicaments	60442838, 65586162, 66287152
GB	Medicines & Healthcare Products Regulatory Agency	109714, 109717, 109808, 109810, 109813, 112763, 178966, 178968, 178969, 178971, 324738
HK	Department of Health Drug Office	55437, 55462, 55479
IE	Health Products Regulatory Authority	17118, 17120, 17125, 17136, 17143, 34565, 34571, 34574, 34586, 34605, 34608
IL	מִשְׂרַד הַבְּרִיאוּת	6091, 6144, 6236, 7326
JP	医薬品医療機器総合機構	7990003F1028, 7990003F2024
LT	Valstybinė vaistų kontrolės tarnyba	1028217, 1028218, 1028219, 1028220, 1028221, 1028222, 1028223, 1028224, 1028225, 1028226, 1028227, 1061950, 1061951, 1074095, 1074096, 1074097, 1074098, 1074099, 1074100, 1074101, 1074102, 1074103, 1074105, 1074106, 1085096, 1085097
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	339M2006
NL	Z-Index G-Standaard, PRK	82597, 82600, 82619
NZ	Medicines and Medical Devices Safety Authority	12360, 12361, 13087
PL	Rejestru Produktów Leczniczych	100164017, 100164023, 100164030
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64807002, W64808001, W64808002, W64808003
SG	Health Sciences Authority	13322P, 13323P
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308097484, 8681308097491, 8681308097514, 8681308097521, 8681308098863, 8699532097507
ZA	Health Products Regulatory Authority	41/34/0574